Dr. Boules Salib, MD, MPH

Dr. Salib practices at Cedars-Sinai Medical Care Foundation in Beverly Hills, California.

Dr. Salib's NPI, 1437302692, was assigned on October 30, 2008. Dr. Salib graduated from Cairo University School of Medicine in 1999. Dr. Salib holds California license A125934.

Dr. Salib's primary practice is Cedars-Sinai Medical Care Foundation, at 8501 Wilshire Blvd, Beverly Hills, CA 90211 in Los Angeles County. The practice phone is (310) 385-3200.

Dr. Salib's primary practice is Cedars-Sinai Medical Care Foundation in Beverly Hills, California. Dr. Salib is also affiliated with Cedars-Sinai Medical Center. The medical group on file is Cedars-Sinai Medical Group. Dmand AI also links Dr. Salib to 1 more physician office and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Salib practices, 3 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Salib's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dr. Salib is board certified in internal medicine by the American Board of Internal Medicine. Dmand AI has Dr. Salib's licenses on file in 3 states: California, New Jersey and New York.

Dmand AI lists acid reflux, acute kidney failure, acute mini-stroke (TIA), acute sinusitis, acute skin infection, anxiety, aortic atherosclerois and arthritis among the conditions Dr. Salib treats.

CMS data shows 1,939 Medicare services from Dr. Salib across 26 procedure codes in 2024, for 415 Medicare patients. Medicare paid $138,845 for them. Every service was in an office.

CMS counts 415 Medicare patients who saw Dr. Salib in 2024. The largest group is 65 to 74, with 183 patients. 75% of them have high cholesterol, and 72% have high blood pressure. 17% are also on Medicaid. Their average risk score is 1.37, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Salib's median patient age at 66, with 52% women.

In 2024, Dr. Salib wrote 6,051 Medicare Part D claims for 553 patients. 89% of them were for generic drugs. CMS names the drug for 5,259 of them, across 117 drugs with 11 or more claims each, at $328,261 in total drug cost. In 2023, CMS named 7,645 claims across 132 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 89 out of 100 for Dr. Salib for performance year 2024, reported as part of a group. Dr. Salib accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Salib as offering telehealth.

Removal of tissue: 1 to 10 procedures (CMS shows small counts as a range)

CMS Open Payments shows 4 general payments to Dr. Salib from 3 drug and device companies from 2023 to 2025. Food and beverage make up the largest share, 100% of the total. Abbott Laboratories paid the most, $233.

Dr. Salib graduated from Cairo University School of Medicine in 1999. Dr. Salib is a member of ACP and SGIM.

Dr. Salib is in network with 13 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. PPO plans come from the most carriers, 9. Check the plan with the practice before a visit.